Cargando…
Anti-NMDA and Anti-AMPA Receptor Antibodies in Central Disorders: Preclinical Approaches to Assess Their Pathological Role and Translatability to Clinic
Autoantibodies against NMDA and AMPA receptors have been identified in the central nervous system of patients suffering from brain disorders characterized by neurological and psychiatric symptoms. It has been demonstrated that these autoantibodies can affect the functions and/or the expression of th...
Autores principales: | Olivero, Guendalina, Roggeri, Alessandra, Pittaluga, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573896/ https://www.ncbi.nlm.nih.gov/pubmed/37834353 http://dx.doi.org/10.3390/ijms241914905 |
Ejemplares similares
-
Somatostatin, a Presynaptic Modulator of Glutamatergic Signal in the Central Nervous System
por: Pittaluga, Anna, et al.
Publicado: (2021) -
Presynaptic Release-regulating Metabotropic Glutamate Receptors: An Update
por: Olivero, Guendalina, et al.
Publicado: (2020) -
Presynaptic Release-Regulating Sphingosine 1-Phosphate 1/3 Receptors in Cortical Glutamatergic Terminals: Adaptations in EAE Mice and Impact of Therapeutic FTY720
por: Roggeri, Alessandra, et al.
Publicado: (2023) -
Antibodies Against the NH(2)-Terminus of the GluA Subunits Affect the AMPA-Evoked Releasing Activity: The Role of Complement
por: Cisani, Francesca, et al.
Publicado: (2021) -
Presynaptic 5-HT(2A)-mGlu2/3 Receptor–Receptor Crosstalk in the Prefrontal Cortex: Metamodulation of Glutamate Exocytosis
por: Taddeucci, Alice, et al.
Publicado: (2022)